Clinical Trial Update: Drug Interaction Study of an OCP (Norethindrone (ND) Acetate and Ethinyl Estradiol (EE))With a Combination of Daclatasvir (DCV) Asunaprevir (ASV) and BMS-791325 [Phase 1]

View source ↗

Summary

A Phase 1 drug-interaction study evaluated the effects of an oral contraceptive containing norethindrone acetate and ethinyl estradiol when combined with daclat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Asunaprevir (asunaprevir)
• BMS-791325
• Daclatasvir (daclatasvir)
• Norethindrone acetate (Norethindrone acetate)
• ethinyl estradiol (ethinyl estradiol)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Hepatitis C | Phase 1 | Status: COMPLETED